BASINGSTOKE-based Shire Pharmaceuticals hopes to launch new treatment for kidney disease before the end of the year.
It follows a letter from the US Food and Drug Administration which the company says is a positive step. Dr Wilson Totten, group research and development director of Shire, said: "This letter is excellent news.''
He says that for dialysis patients treated across the United States, the new drug will be a welcome new and effective alternative to current therapies.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article